| High Risk HPV Assay (138-0020) | |
|---|---|
| Test Mnemonic: | HIRISKHPV |
| Specimen Requirements: | |
| Test Included: |
This test can identify 13 high-risk types of HPV associated with the development of cervical cancer.
|
| Collection: | Collect cervical specimen using the Digene collection kit (available through UTMB Materials Management); or collect cervical sample using SurePath collection kit. |
| Container: | Digene transport medium or SurePath pap smear container |
| Minimum Volume: | 1ml |
| Storage/Transport: | Transport at room temperature or refrigerated temperature. |
| Specimen Preparation: | Submit specimen in Digene transport medium ; or submit specimen in SurePath transport medium. |
| Stability: | Digene collection - Ambient: 2 weeks; Refrigerated: 3 weeks; Frozen: 3 months; or SurePath transport medium: Refrigerated: 1 month; Frozen: Unacceptable |
| Causes for Rejection: | Incomplete and/or incorrect sample identification, collection not utilizing Digene or SurePath Collection Kit |
| Reference Range: | Not detected |
| Turnaround Time: | 3-14 days |
| Methodology: | Hybrid capture |
| Performed: | Molecular Diagnostics Laboratory |
| Synonyms: | HPV; Human Papiloma virus test; High Risk HPV test; Genital warts test |
| Clinical Indication: | Screen for high risk human papilloma viruses |
| Patient Preparation : | Sample is collected during cervical examination |
| CPT 4 Code: | 87620 |
| Note: | For co-testing of HPV and Pap smear, please order HPV test in addition to Pap smear test. Digene sample for HPV test is FDA approved and preferred. |
| When ordering tests for which Medicare or Medicaid reimbursement will be sought, physicians should only order tests that are medically necessary for the diagnosis or treatment of the patient. Components of the organ or disease panels may be ordered individually. The diagnostic information must substantiate all tests ordered and must be in the form of an ICD-10 code or its verbal equivalent. | |